Matches in Wikidata for { <http://www.wikidata.org/entity/Q94088583> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q94088583 description "article scientifique publié en 2018" @default.
- Q94088583 description "wetenschappelijk artikel" @default.
- Q94088583 description "наукова стаття" @default.
- Q94088583 name "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 name "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 type Item @default.
- Q94088583 label "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 label "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 prefLabel "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 prefLabel "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 P1433 Q94088583-195FBB3B-D6FE-4EB9-B621-08EF2664502B @default.
- Q94088583 P1476 Q94088583-F68BFFBB-BB89-4254-BBA5-D4316CF91703 @default.
- Q94088583 P2093 Q94088583-29395641-B415-4B88-9037-6B36F891E7D1 @default.
- Q94088583 P2093 Q94088583-2BEAEB57-43E9-481E-B9DF-AC0C53057A6E @default.
- Q94088583 P2093 Q94088583-5B3863D9-42FF-43E0-9089-858675E7BE44 @default.
- Q94088583 P2093 Q94088583-8F0B043E-5E1B-419D-8D5E-EAEBEE7FEB9F @default.
- Q94088583 P2093 Q94088583-9DB091B1-CF54-48DE-913C-54D272E3F762 @default.
- Q94088583 P2093 Q94088583-A25D95C6-79CE-48C6-81CE-2D5ACCB3CA7C @default.
- Q94088583 P2093 Q94088583-E61AB3AC-F686-45D2-98E4-11945B00FB94 @default.
- Q94088583 P2093 Q94088583-E83C6072-1C31-4626-87E9-64E6735C9BF8 @default.
- Q94088583 P304 Q94088583-BA366AA7-23C5-451D-9B9A-B3D8BDA5B925 @default.
- Q94088583 P31 Q94088583-428CA495-B745-48CD-978F-D10687E916ED @default.
- Q94088583 P356 Q94088583-DF9A2BDC-2771-48EA-9502-CCD42C8F0F43 @default.
- Q94088583 P433 Q94088583-49F6581F-35A3-4976-9AB5-F56B8C79E7DF @default.
- Q94088583 P478 Q94088583-B62B3A1A-9745-4018-8090-290358A04833 @default.
- Q94088583 P577 Q94088583-8752DF7F-7583-416F-8F01-93CF88C10B11 @default.
- Q94088583 P921 Q94088583-368271F5-51F5-4455-AB33-496E8D47D9C6 @default.
- Q94088583 P932 Q94088583-D70D0964-6058-4423-AD9A-F91F70115973 @default.
- Q94088583 P356 NOY139.245 @default.
- Q94088583 P1433 Q15724471 @default.
- Q94088583 P1476 "P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor" @default.
- Q94088583 P2093 "B Lohmann" @default.
- Q94088583 P2093 "C von Achenbach" @default.
- Q94088583 P2093 "E Le Rhun" @default.
- Q94088583 P2093 "E Szabo" @default.
- Q94088583 P2093 "H Schneider" @default.
- Q94088583 P2093 "K Meetze" @default.
- Q94088583 P2093 "M Silginer" @default.
- Q94088583 P2093 "M Weller" @default.
- Q94088583 P304 "iii280-iii280" @default.
- Q94088583 P31 Q13442814 @default.
- Q94088583 P356 "10.1093/NEUONC/NOY139.245" @default.
- Q94088583 P433 "Suppl 3" @default.
- Q94088583 P478 "20" @default.
- Q94088583 P577 "2018-09-19T00:00:00Z" @default.
- Q94088583 P921 Q282142 @default.
- Q94088583 P932 "6144666" @default.